NCT06760481View on ClinicalTrials.gov

Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 13, 2025

Primary Completion Date

September 15, 2028

Study Completion Date

September 15, 2030

Conditions
Advanced Solid Malignancies
Interventions
DRUG

Tiragolumab

Given by IV

DRUG

Atezolizumab

Given by IV

RADIATION

Radiation Therapy

Given by IV

Trial Locations (1)

77030

The University of Texas M. D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT06760481 - Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER) | Biotech Hunter | Biotech Hunter